Fang Tian
About Fang Tian
Fang Tian is the Lead Scientist and Head of Cell Biology R&D at ATCC, where he has worked since 2011. He specializes in developing high-value cell lines for research and drug development, while also contributing to international biotechnology standards and cell line authentication efforts.
Work at ATCC
Fang Tian has been serving as the Lead Scientist and Head of Cell Biology R&D at ATCC since 2011. In this role, he leads a team responsible for the preparation, authentication, and quality control of over 3,400 accessioned animal cell lines and hybridomas. His work focuses on developing scientific high-value cell lines derived from various normal and tumor tissues, which are essential for basic research and drug development. Under his leadership, the team emphasizes the development of advanced cell models that incorporate genetic alterations, molecular pathology, and cancer-immunology.
Education and Expertise
Fang Tian studied at the Chinese Academy of Science, where he specialized in Pharmacology and earned his Ph.D. His educational background provides a strong foundation for his extensive research experience in areas such as CRISPR genome editing, cancer genomics, and cancer immunology. He possesses significant expertise in program leadership, cross-functional team management, and business planning and strategy, which enhances his contributions to the field of biotechnology.
Background
Fang Tian has accumulated over 13 years of experience in his current position at ATCC. He is actively involved in the US Technical Advisory group to ISO/TC276 Technical Committee, where he contributes to the development of international standards in biotechnology. Additionally, he participates in the International Cell Line Authentication Committee (ICLAC), focusing on the authentication of cell lines utilized in research, which underscores his commitment to maintaining high standards in scientific research.
Achievements
Fang Tian has demonstrated success in the fields of oncology and anticancer drug development, resulting in numerous publications and patents. His contributions to the development of advanced cell models and high-value cell lines have significantly impacted basic research and drug development. His involvement in international committees and standardization efforts further highlights his role in advancing biotechnology practices.